The cellular origins of TGF-β1 in the TME include the tumor per se, as well as infiltrating immune and inflammatory cells, including neutrophils, macrophages/monocytes, and Tregs in particular, with the cytokine acting via both autocrine and paracrine signaling. The gene discussed is TGFB1; the disease is neoplasm.